Find out about the latest news from Oxford Gene Technology.
- 9 November 2020
OGT’s NGS panels to be featured in user workshop at AMP 2020
In the workshop users will explain how OGT’s SureSeq™ NGS panels can increase throughput and save time and cost in the detection of a wide variety of aberrations.
- 3 November 2020
OGT expands NGS cancer panel offering
Launch of two NGS panels enables comprehensive detection of genetic abnormalities involved in breast and ovarian cancer, and myeloid disorders.
- 22 July 2020
NHS study confirms higher reporting rate for OGT’s CytoSure v3 array
Paper published in npj Genomic Medicine demonstrates identification of more reportable CNVs with CytoSure v3 vs traditional array design.
- 6 July 2020
OGT’s Cytocell portfolio available via Sysmex in China and Spain
Addition of direct-sales territories follows successes across Europe and APAC and provides customers with enhanced local sales and support services.
- 6 April 2020
OGT delivers translocation and partial tandem duplication detection
New content and Interpret NGS analysis software detection capabilities include BCR-ABL and KMT2A-PTD detection.
- 23 March 2020
OGT’s response during the COVID-19 outbreak
During these unprecedented times, OGT remains committed and ready to support you...
- 5 March 2020
Sysmex and the Kobe City Eye Hospital sign collaboration agreement
Reinforcing collaboration toward the realisation of genomic medicine in the area of ophthalmic disorders
- 6 February 2020
Sysmex Inostics and OGT combine in breast cancer FFPE / ctDNA research
Plasma and tissue sequencing demonstrate clearance of ctDNA correlates with pathologic complete response in breast cancer patients during neoadjuvant treatment.
- 30 January 2020
OGT launches breakthrough NGS panel for constitutional cytogenetics
Robust panel enables accurate and comprehensive constitutional genetic aberration screening in one assay.
- 13 January 2020
OGT unveils reliable somatic CNV detection for CLL with new NGS panel
SureSeq™ CLL + CNV - comprehensive CLL genomic profiling from a single assay
- 10 December 2019
OGT develops transformative constitutional NGS panel
CytoSure™ NGS – Combining the benefits of microarrays and NGS in a single assay
- 18 November 2019
OGT continues move into molecular diagnostics markets
MDSAP certification of new Cambridge facility smooths path to future IVD approvals.
- 13 June 2019
OGT makes market-leading NGS coverage and expertise more accessible
SureSeq™ complete library preparation solution delivers unparalleled data quality
- 6 June 2019
OGT celebrates opening of new Cambridge site
State-of-the-art premises increases operational footprint and will host Sysmex global R&D facility
- 26 February 2019
OGT to open new Cytocell facility in Cambridge, UK
Sysmex demonstrates confidence and investment in OGT and the United Kingdom